Amrize Ltd filed a quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, disclosing condensed consolidated financial statements and related management discussion.

Key Highlights

  • Q2 2026 Revenue: Amrize reported revenues of $3,494 million for the three months ended June 30, 2026, compared with $3,218 million for the same period in 2025.
  • First-Half Revenue: For the six months ended June 30, 2026, the company reported revenues of $5,675 million, up from $5,307 million in the first half of 2025.
  • Cost of Revenues: Cost of revenues for the three months ended June 30, 2026 was $2,501 million, versus $2,277 million in Q2 2025.
  • Six-Month Cost of Revenues: Cost of revenues for the six months ended June 30, 2026 totaled $4,474 million, compared with $4,129 million in the prior-year period.
  • Shares Outstanding: As of July 31, 2026, the number of outstanding Ordinary Shares was 546,925,644, net of Treasury Shares.
  • Exchange Listing: Amrize Ltd Ordinary Shares (par value $0.01 per share) trade on the New York Stock Exchange under the ticker symbol AMRZ.

Amrize Ltd Q2 2026 Revenue and Cost Trends

According to the filing, Amrize Ltd, a Switzerland-incorporated company headquartered in Zug, reported quarterly revenues of $3,494 million for the three months ended June 30, 2026, an increase from $3,218 million in the comparable prior-year quarter. The company's cost of revenues for the same three-month period was $2,501 million, compared with $2,277 million in Q2 2025. The filing presents these figures in millions, except per share data, and notes the statements are unaudited.

For the six-month period ended June 30, 2026, the company disclosed revenues of $5,675 million against $5,307 million for the six months ended June 30, 2025. Cost of revenues on a six-month basis rose to $4,474 million from $4,129 million in the year-earlier period. The filing identifies Amrize as a large accelerated filer and confirms it is not a shell company.

The filing notes that Amrize was separated from Holcim Ltd and references its limited history operating as an independent, publicly traded company. The company's Quarterly Report includes forward-looking statements, which it cautions "are based on assumptions that we believe in good faith are reasonable but which may be materially different from actual results," subject to risks including demand in the construction industry, raw material costs, energy and fuel costs, and factors related to the separation from Holcim.

What Was Disclosed

Amrize Ltd's Form 10-Q for the period ended June 30, 2026 disclosed unaudited condensed consolidated income statement data covering Q2 and the first half of 2026, share count as of July 31, 2026, and exchange listing information for its Ordinary Shares on the NYSE.